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RalA and RalB are small GTPases that are involved in cell migration and membrane dynamics. We used transgenic mice in
which one or both GTPases were genetically ablated to investigate the role of RalGTPases in the Schwann cell (SC) response to
nerve injury and repair. RalGTPases were dispensable for SC function in the naive uninjured state. Ablation of both RalA and
RalB (but not individually) in SCs resulted in impaired axon remyelination and target reinnervation following nerve injury,
which resulted in slowed recovery of motor function. Ral GTPases were localized to the leading lamellipodia in SCs and were
required for the formation and extension of both axial and radial processes of SCs. These effects were dependent on
interaction with the exocyst complex and impacted on the rate of SC migration and myelination. Our results show that
RalGTPases are required for efficient nerve repair by regulating SC process formation, migration, and myelination, therefore
uncovering a novel role for these GTPases.
Introduction
Peripheral nerve injury results in marked transcriptional and
phenotypic changes within Schwann cells (SCs), which are
critical for effective nerve repair (Jessen et al., 2015; Jessen and
Mirsky, 2016). SCs are involved in every phase of the initial
nerve injury response and required for subsequent repair (Chen
et al., 2007). After injury, the distal stump undergoes Wallerian
degeneration (Griffin et al., 2013). Axonal death triggers SC
dedifferentiation (Arthur-Farraj et al., 2017; Clements et al.,
2017). SCs contribute to the clearance of axonal- and myelin-
derived debris (Gomez-Sanchez et al., 2015). SCs proliferate
and fill the empty endoneurial tubes in organized longitudinal
columns called bands of Büngner. These “repair” SCs undergo
significant morphological transitions as they elongate and guide
axons back to their targets (Fazal et al., 2017). There is a close
association between SC processes and axons (Arthur-Farraj
et al., 2012). Following complete nerve transection, SCs mi-
grate and form bridges to aid the crossing of axons from prox-
imal to distal nerve stumps (Parrinello et al., 2010). Finally, SCs
envelop the regenerated axons, large-diameter axons are re-
myelinated, and small-diameter axons will be enclosed in SC
“pockets” of nonmyelinating (Remak) SCs (Arthur-Farraj et al.,
2012). This supportive environment is critical for successful
axonal regeneration (Grinsell and Keating, 2014), and these
events require extensive changes in SC process formation and
extension.
Ral small GTPases, encoded by the Rala and Ralb genes, are
members of the RAS superfamily of small GTPases (Bodemann
and White, 2008). Like all GTPases, Ral proteins transduce
signals in cells by cycling between an active GTP-bound and an
inactive GDP-bound state (Feig, 2003). Overall, the RalGTPases
RalA and RalB share 85% of sequence identity (Neel et al., 2011).
RalA and RalB can have redundant functions (Peschard et al.,
2012). The role of RalGTPases in the cells is due to their distinct
subcellular membrane localization: RalA is found in the plasma
membrane, cytoplasm, and perinuclear area, usually within
endosomes, while RalB is primarily endosome-associated
(Shipitsin and Feig, 2004). Also, their localization can be reg-
ulated by the activation state and phosphorylation (Cascone
et al., 2008; Neel et al., 2011). RalGTPases have been impli-
cated in a variety of neuronal processes, such as neural tube
closure, neurite branching, cytoskeletal reorganization, and
membrane dynamics (Lalli and Hall, 2005; Peschard et al., 2012;
Das et al., 2014). The role of RalGTPases in glia has not been
examined; however, they can interact with a number of
downstream pathways, which could have an important impact
on SC function. RalGTPases’ effector Ral binding protein
1 (RalBP1) can deactivate cdc42 and Rac1 in the plasma mem-
brane via intrinsic GTPase-activating activity, dephosphor-
ylating cdc42 and Rac1 to the inactive GDP state (Matsubara
et al., 1997). These small GTPases are both important for
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developmental myelination and remyelination after nerve in-
jury in adulthood (Guo et al., 2012, 2013).
A further important pathway through which Ral GTPases can
impact on membrane trafficking and cell migration is via the
exocyst complex, an octameric protein complex involved in the
tethering and spatial targeting of vesicles to the plasma mem-
brane before vesicle fusion (TerBush et al., 1996; Sugihara et al.,
2002; Liu and Guo, 2012). This complex has been shown to have
a role in polarized delivery of cargoes in a number of cell types,
including epithelial cells and neurons (Vega and Hsu, 2001;
Yeaman et al., 2001; Lalli and Hall, 2005; Feng et al., 2012; Das
et al., 2014). Active RalGTPases regulate the exocyst complex by
direct binding to two of its components: Exoc2 and Exoc8
(Moskalenko et al., 2002). We have investigated the role of
RalGTPases in SCs during nerve injury and repair. We have
found that RalGTPase signaling is important for multiple aspects
of regeneration, including remyelination and muscle reinner-
vation. RalGTPase signaling has an important role in the for-
mation and extension of SC processes, SC migration, and axon
myelination, which occurs in an exocyst-dependent manner.
Results
RalGTPases expression and activation state after nerve injury
We examined RalGTPases expression in the regenerating distal
nerve stump following sciatic nerve crush (Fig. 1). We analyzed
three time points after nerve injury: (1) 4 d, when SCs dedif-
ferentiate and proliferate, macrophages infiltrate the nerve, and
myelin clearance occurs; (2) 11 d, when SCs organize in the
bands of Bungner and remyelination of axons by SCs begins; and
finally, (3) 28 d, when almost all the axons are reinnervating
their targets and are remyelinated (Fig. 1 A). There was a sig-
nificant decrease in the levels of RalA at 11 d and a nonsignificant
trend to decrease at 4 and 28 d after crush compared with
noninjured nerves (Fig. 1, B and C). In contrast, the levels of RalB
were significantly increased at all the time points analyzed fol-
lowing injury versus control (Fig. 1, B and E). As has been de-
scribed in the literature, changes in the expression are not
necessarily correlated with activation status of RalGTPases
(Peschard et al., 2012); therefore, we measured the amount of
activated GTP-RalA plus RalB after injury. In contrast to total
expression levels of RalA, there was a trend to increased RalA
activation across all time points, although this did not reach
significance (Fig. 1, B and D). RalB activation state after injury
showed a trend to decrease at 4 d and a significant decrease at
28 d (Fig. 1, B and F). Thus, expression and activation state of
RalGTPases are not correlated after nerve injury, so we inves-
tigated the effect of genetic deletion of RalGTPases in the nerve
injury paradigm to gain further insight into their role in nerve
regeneration.
Given that SCs are a major cellular component of the pe-
ripheral nerve and the significant membrane remodeling re-
quired for remyelination, we examined the expression of
RalGTPases in this cell type, staining with RalA antibody in
cultured primary rat SCs. The IHC showed RalA in the peri-
nuclear cytoplasmic region and cell nucleus, as described in
other cell types. Notably, however, there was also enrichment
of staining in the membrane edge of the lamellipodia (Fig. 1, G
and G’).
Global ablation of RalB or SC-specific ablation of RalA are
dispensable for axon regeneration, remyelination, and
functional recovery after peripheral nerve injury
To study the role of RalA and B in peripheral nerve regeneration,
we initially examined these molecules individually after crush
(Fig. S1 A and Fig. S2 B). RalB−/− mice have a global ablation of
RalB protein (Peschard et al., 2012), which we observed in the
sciatic nerve (Fig. S1 B). Ultrastructural analysis of the distal
sciatic nerve 1 mo after crush demonstrated no significant dif-
ference between RalB−/− and WT littermate controls in the
number of myelinated or unmyelinated axons (Fig. S1, C–F),
myelin morphology (Fig. S1, G and I), axon diameter (Fig. S1 H),
or Remak bundle structure (Fig. S1, J and K). There was no
significant change in internodal length (Fig. S1 L) or reinner-
vation of the neuromuscular junction (Fig. S1 M). Consistent
with the anatomical findings, there was no significant difference
in the rate of functional recovery assessed using the sciatic
functional index (SFI), a measure of motor function (Fig. S1 N),
and the pin prick test which is a reflection of sensory afferent
regeneration to the skin (Fig. S1 E).
Global deletion of RalA is embryonically lethal due to exen-
cephaly (Peschard et al., 2012). We therefore used a conditional
approach focusing on the role of RalA in SCs. We crossed RalAf/f
mice with PLPCreERT2 to get PLPCreERT2;RalAfl/fl (herein called
cRalA). In these mice, tamoxifen-inducible Cre expression is
driven by the PLP (proteolipid protein) promoter, which is ex-
pressed in SCs. Recombination of the conditional RalA alleles
after tamoxifen induction in cRalA led to a strong reduction in
RalA protein expression levels in sciatic nerve lysates from
mutant mice in both noninjured and injured nerves (Fig. S2 A).
The residual expression of RalA was likely due to the expression
of this protein in fibroblasts and axons, as well as a few non-
recombined SCs. We also studied for possible compensation in
RalB, analyzing the expression of RalB in cRalA mice byWestern
blot in noninjured and injured nerves (Fig. S2 A). The expression
of RalB did not change in either ipsilateral or contralateral
nerves (Fig. S2 A). There was no difference between cRalA and
control mice in nerve repair in any of the anatomical or func-
tional outcomes measured (Fig. S2, C–O). In summary, RalA
(conditionally ablated in SCs) and RalB (global deletion) are
dispensable for nerve repair when studying the mutant alleles
individually.
Efficient ablation of RalA on cRalA/B−/− mice
To study the effect of RalGTPases on nerve repair, we used a
combination of the knockout (KO) for RalB (RalB−/−) with the SC
conditional KO of RalA (cRalA), here named cRalA/B−/− mice.
Since cRalA is a conditional model, we investigated RalA ablation
in the cRalA/B−/− mice (Fig. 2 A). In both noninjured and injured
mice, there was a significant reduction in RalA protein as as-
sessed usingWestern blot (Fig. 2 B). In addition, immunostaining
of teased fibers was performed to assess localization of RalA. As
shown in Fig. 2 C in control mice, RalA was predominantly
localized in SCs (in both noninjured and injured nerves). We
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also confirmed the ablation of RalA in SCs in the cRalA/B−/−
mice (Fig. 2 C).
SC-specific ablation of RalA in RalB−/− mice results in a
hypomyelination of axons, reduced target reinnervation, and a
delay in the functional recovery
To focus on SC function after nerve injury, we generated cRalA/
B−/− mice in which the expression of RalA in SCs is conditionally
ablated in RalB−/− mice. One month after tamoxifen treatment,
cRalA/B−/− were completely healthy. 2 mo after tamoxifen dos-
ing and 1 mo after crush, the sciatic nerve contralateral to the
injury was used to assess the impact of RalGTPases on uninjured
nerve. Ultrastructural analysis revealed no difference in myeli-
nated and nonmyelinated axon count or g-ratio (Table 1)
between tamoxifen-treated RalAfl/fl;RalB−/− Cre-negative (here-
after referred to as “ctrl”) and cRalA/B−/− mice.
12 d after nerve crush, many axons 2 mm distal to the crush
site were observed undergoing remyelination in ctrl mice. In
contrast, in cRalA/B−/− mice, we noted more axons with a di-
ameter of >1 µm that were unmyelinated (Fig. 3 A and Table 2).
Furthermore, the axons that were remyelinated had thinner
myelin sheaths reflected in a considerable and significant in-
creased g-ratio (Table 2). At the later time point of 1 mo after
injury, the g-ratio and the number of unmyelinated axons with a
diameter of >1 µm was still higher in cRalA/B−/− than in the ctrl
mice (Fig. 3 A and Table 2). The number of axons in the distal
sciatic nerve (Fig. 3, B and C), the C-fibers per Remak bundle,
and the number of Remak bundles in the injured nerve did not
significantly differ between ctrl and cRalA/B−/− (Fig. 3 and
Table 2) at both time points analyzed. There was a significant
decrease in the internodal distance in teased myelinated nerve
fibers 1 mo after injury in cRalA/B−/−mice versus ctrl littermates
Figure 1. Dysregulation of RalGTPase ex-
pression, activation after nerve injury and
their expression in SCs in vitro. (A) Schematic
representation of the sciatic nerve crush model
used to assess the role of RalGTPases on nerve
repair. (B) Western blot of injured (inj) and
noninjured (non-inj) sciatic nerves 4, 11, and 28 d
after sciatic nerve crush in WT mice probed
with antibodies against RalA and RalB. Calnexin
(CAL) used as loading control. Immunoprecipi-
tation blot of activated forms of RalA and RalB.
(C–F) Quantification of the relative protein ex-
pression of RalA (C) and RalB (E) across the time
points analyzed in the Western blots. Quantifi-
cation of the relative protein expression of active
RalA (D) and active RalB (F) across the time
points. Data are presented as fold change against
noninjured relative expression (**, P < 0.01; *,
P < 0.05; Student’s t test), n = 4 or 5. Data are
presented as mean ± SEM. (G) Primary cultures
of rat SCs demonstrate expression of endoge-
nous RalA (green) in the nucleus, perinuclear
cytoplasm, and in the plasma membrane.
(G’) High magnification picture shows an en-
richment of RalA in the membrane edge of la-
mellipodia (arrow bars). Scale bars, 50 µm.
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(Fig. 3, B and C). To summarize, in the absence of RalA and B in
SCs, there is reduced axon remyelination characterized by more
large axons that are unmyelinated, increased g-ratio, and
shorter internodes. To test whether disrupted RalGTPase ex-
pression led to a change in the target reinnervation by motor
axons, we assessed innervation of neuromuscular junctions
within the gastrocnemius muscle 4 wk after injury. We noted
impaired reinnervation of the neuromuscular junction in cRalA/
B−/− mice versus ctrl as determined by a reduced occupancy
of the postsynaptic acetylcholine receptors (revealed by
α-Bungarotoxin labeling) by presynaptic motoneuron terminals
(Fig. 3, D and E). Although we did not observe changes in the
number of axons in the nerve trunk, cRalA/B−/− mice do show
impaired reinnervation of distal targets.
In assessing functional recovery following injury, in both
cRalA/B−/− and ctrl mice, there was a marked drop in SFI im-
mediately after crush that reached the same nadir in both gen-
otypes. cRalA/B−/− mice had a slower recovery of the SFI
following injury versus ctrl (which significantly differed from
ctrl at days 12 and 14; Fig. 3 F). The pin prick test was comparable
between ctrl and cRalA/B−/− littermates (Fig. 3 G).
Macrophage recruitment, myelin clearance, and SC
proliferation are not altered following nerve injury in cRalA/
B−/− mice
Early events in Wallerian degeneration following peripheral
nerve injury are the de-differentiation of the SCs, recruitment of
macrophages, and subsequent removal of myelin debris by both
cell types. To examine whether RalGTPases expression in SCs
plays a role in these processes, macrophages and myelin ovoids
contained within macrophages and SCs were counted in both
tamoxifen-treated cRalA/B−/− and ctrl mice (Fig. 4, B–D) 4 d after
crush. As shown by micrographs analysis, in both mutant
nerves, there were clear features ofWallerian degeneration with
macrophage infiltration and collapsed myelin resulting in ovoid
formation (Fig. 4 B). However, there was no change in the
number of macrophages (Fig. 4 C), nor in the number of myelin
ovoids contained within them (Fig. 4 D) between genotypes.
Figure 2. Analysis of RalA expression in cRalA/B−/−mice. (A) Schematic representation of the nerve crush experiment. Tx, Tamoxifen. (B)Western blots of
noninjured and injured nerves showing RalA expression in ctrl and CRalA/B−/− mice. GAPDH used as loading control. Data are presented as mean ± SEM.
(C) Teased fibers staining of noninjured (non-inj) and injured (inj) nerves 4 wk after injury, ctrl versus cRalA/B−/−. RalA is labeled in green, and S100 for SCs
localization is labeled in red. RalA is predominately expressed in SCs, and it is ablated after tamoxifen treatment. n = 3.
Table 1. Summary of nerve anatomy measurements in non-injured
nerves
Non-injured Ctrl cRalA/B−/−
Myelinated axons × 1,000/mm2 7.15 ± 0.72 7.65 ± 0.26
Unmyelinated axons × 1,000/mm2 46.78 ± 8.66 48.68 ± 4.18
g-ratio 0.845 ± 0.005 0.879 ± 0.006
Quantification of the total number of myelinated axons, unmyelinated
axons, and g-ratio was unchanged in non-injured nerves of cRalA/B−/− versus
ctrl. Number of animals = 4. Number of quantified fibers per animal at 12 d =
50. Number of quantified fibers per animal at 1 mo = 150.
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Also, there was no change in the myelin basic protein (MBP)
immunoblot between genotypes (Fig. 4, E and F), indicating that
there is not a delay in myelin clearance and macrophage re-
cruitment following peripheral injury in cRalA/B−/− mice com-
pared with ctrl mice.
We analyzed the expression of the proliferation marker Ki67
in sciatic nerve longitudinal sections of cRalA/B−/− and ctrl mice
12 d after injury. We did not detect any difference in cell pro-
liferation between cRalA/B−/− and ctrl mice (Fig. 5, A and B). We
also performed a proliferation assay in vitro in cultured SCs
from WT and cRalA/B−/− mice. Cultured mice SCs from both
genotypes were treated with 4-hydroxytamoxifen (4-OHT; a
tamoxifen metabolite used for in vitro experiments) for 3 d. 2 d
later, we stopped the treatment to see if this was effective in
reducing RalA and B expression (Fig. 5 C). Tamoxifen-treated
cRalA/B−/− showed a significant decrease in RalA expression
compared with WT mice assessed by immunoblot for RalA. We
also noted that RalB protein expression in cRalA/B−/−-derived
cultured SCs is decreased compared with WT (Fig. 5, D–F). We
did not observe any significant change in proliferation, assessed
by immunostaining for the proliferation marker Ki67, in cRalA/
B−/− compared with WT (Fig. 5, G and H). These results suggest
that RalGTPases are not implicated in SC proliferation in vitro or
after nerve injury.
Figure 3. RalGTPases are required for re-
myelination, neuromuscular junction rein-
nervation, and optimum functional recovery
following peripheral nerve injury. (A) Electron
micrographs of transverse sections of the distal
sciatic nerve 12 d and 1 mo after crush in control
(Ctrl) and cRalA/B−/−. At 12 d in ctrl mice, most
axons are undergoing remyelination, whereas in
cRalA/B−/− mice, some axons with >1 µm diam-
eter are still without myelin (arrowheads), and
the ones that are myelinated have thinner myelin
sheaths (black asterisk). (B) Representative
photomicrographs of teased nerve fibers stained
with osmium to analyze internodal distance of
the distal sciatic nerve 1 mo after crush in ctrl
and cRalA/B−/− mice. (C) Quantification of in-
ternodal distance, *, P < 0.05, Student’s t test,
n = 4. (D) Representative photomicrographs of
neuromuscular junctions within the gastrocne-
mius muscle of cRalA/B−/− and ctrl. SV2 and 2H3
label presynaptic motoneuron axons and termi-
nals (white), and α-bungarotoxin (α-B) labels
post-synaptic acetylcholine receptor (AchR; red).
Highlighted in the white squares are represen-
tative high-magnification pictures of neuromus-
cular junction endplates stained for SV2/2H3 and
α-bungarotoxin; there is a lack of reinnervation
in the cRalA/B−/− endplate. (E) Quantification of
the number of neuromuscular junctions (NMJ)
reinnervated 1 mo after nerve injury. *, P < 0.05,
Student’s t test, n = 5. (F) cRalA/B−/− mice pre-
sent a significant delay in the functional recovery
between 12 and 14 d after injury assessed using
the SFI compared with control littermates (*, P <
0.05, Student’s t test, n = 8–12). (G) Assessment
of response to pin prick stimulation as a measure
of reinnervation of the paw by nociceptive
afferents. n = 8–12. Data are presented as
mean ± SEM. Scale bars, 10 µm for electronic
micrographs, 100 µm for teased fibers, and
50 µm for neuromuscular junctions.
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RalGTPases control axial SC prolongation length and axial and
radial lamellipodia formation in SCs
During development, SCs develop a cytoplasmic protrusion ra-
dially in relation to the main SC axis, similar to a giant lamel-
lipodia in form and function (Nodari et al., 2007; Parkinson
et al., 2008; Montani et al., 2014). This process is thought to
be necessary for spiral membrane wrapping and myelin for-
mation (Bunge et al., 1989; Feltri et al., 2002). In the first stages
of nerve repair, myelinating and Remak SCs de-differentiate to
repair SCs, adopting an elongated bipolar morphology. After
myelin clearance, de-differentiated SCs align in columns inside
the basal lamina to guide regenerated axons to reinnervate distal
organs (Arthur-Farraj et al., 2012). To analyze the capacity of SCs
lacking RalGTPases to extend and maintain axial and radial
prolongations (major cytoplasmic process extensions of the cell)
and lamellipodia (thin cytoplasmic sheets extended in the SCs;
scheme in Fig. 6 A), we performed SC cultures frommice lacking
both GTPases (Fig. 6 B). We then quantified the axial (at the two
Table 2. Summary of morphometry in injured nerves
Injured 12 d after injury 28 d after injury
Ctrl cRalA/B−/− Ctrl cRalA/B−/−
Myelinated axons × 1,000/mm2 7.15 ± 0.72 7.65 ± 0.26 19.10 ± 1.70 16.28 ± 1.60
Unmyelinated axons × 1,000/mm2 46.78 ± 8.66 48.68 ± 4.18 50.33 ± 12.81 30.15 ± 6.73
% nude axons >1 µm 12.55 ± 1.21 25.71 ± 2.30* 4.57 ± 0.64 9.56 ± 1.18*
g-ratio 0.845 ± 0.005 0.879 ± 0.006* 0.657 ± 0.009 0.693 ± 0.008*
Remak bundles × 1,000/mm2 6.25 ± 1.84 5.35 ± 0.81 6.63 ± 0.87 6.85 ± 0.30
% bundles with polyaxonal pockets 39.45 ± 2.91 50.98 ± 3.83 14.75 ± 3.55 15.92 ± 2.47
C-fibers/Remak bundle 8.39 ± 0.85 7.91 ± 0.42 5.8 ± 0.30 6.12 ± 0.60
Quantification of the total number of myelinated and non-myelinated axons per sciatic nerve cross-section at 12 and 28 d after crush does not show any
difference betweenmice. Quantification of non-myelinated axons of >1 µm diameter at 12 and 30 d after injury shows a clear increase in the percentage of non-
myelinated axons of >1 µm diameter at both time points (*, P < 0.05, Student’s t test). Number of animals = 4. Number of quantified fibers per animal at 12 d =
50. Number of quantified fibers per animal at 1 mo = 150. Quantification of g-ratios 12 and 28 d after crush shows a significant increase in the g-ratio of the
cRalA/B−/− mice compared to control littermates at both time points (*, P < 0.05, Student’s t test, n = 4). Remak bundles, percentage of Remak bundles with
polyaxonal pockets and number of C-fibers per Remak bundle, 12 d and 1 mo after injury, did not show any difference.
Figure 4. RalGTPases are dispensable for macrophage recruitment and myelin clearance following peripheral nerve injury. (A) Schematic repre-
sentation of the nerve crush experiment at day 4. (B) Electron micrographs of transverse sections of sciatic nerve 4 d following crush. Arrows identify
macrophages containing myelin ovoids. (C and D) Quantification of macrophage numbers (C) and myelin ovoid numbers (D). (E) Representative Western blot
pictures for MBP expression in distal sciatic nerve homogenates 4 d after injury. (F) Quantification of relative expression of MBP showing no significant
differences between mice. Data are presented as mean ± SEM. Scale bar, 2 µm.
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extremities of the main cell axis) and radial (perpendicular to
the main cell axis) SC prolongation length and lamellipodia
numbers (Fig. 6 A).
We purified SCs from mouse sciatic nerve and then treated
them with 4-OHT for 3 d. 1 d later they were cultured in new
plates and synchronized with serum deprivation for 1 d in de-
fined medium. After 4 h with expansion medium, we fixed the
cells and analyzed the capability of mutant SCs to develop SC
processes de novo (Fig. 6, B–E). We analyzed the effect of RalA
and RalB ablation individually, and there was no significant
difference in SC process formation using SC cultures derived
from cRalA and RalB−/− mice compared with WT SCs (data not
shown). When comparing SCs lacking both Ral GTPases (cRalA/
B−/−) versus RalB−/−, we observed a significant decrease in both
axial (Fig. 6 D) and radial (Fig. 6 E) lamellipodia formation in
cRalA/B−/−mice compared with RalB−/−. Finally, we analyzed the
length of both radial and axial prolongation (Fig. 6, F–H). No-
tably, although the length of radial SC prolongation was similar
between groups, the length of axial prolongation was reduced in
cRalA/B−/− SCs compared with RalB−/−. These results demon-
strate the role of RalGTPases in (1) axial and radial lamellipodia
formation and (2) axial prolongation length in SCs. This would
provide a cellular mechanism for the axon hypomyelination
observed in vivo (Fig. 3).
RalGTPases enhance axial and radial SC processes through
different effectors
RalGTPases can activate several downstream pathways through
their downstream effectors (Bhattacharya et al., 2004; Lalli and
Hall, 2005; Neel et al., 2011; Teodoro et al., 2013). To determine
whether just one or more effectors are responsible for the al-
teration of SC processes observed in Fig. 6, we used viral vectors
containing constitutive active Ral mutants that have lost the
ability to bind to specific effector proteins and analyzed the
capability to develop SC processes. WT rat SC primary cultures
were transduced with lentivirus containing GFP as a control or
GFP and Ral effector domain mutants. Cells were fixed 2 d after
transduction, and axial and radial prolongations and lamellipo-
dia number and axial and radial prolongation length were ana-
lyzed. To confirm that both viral vectors had the same efficiency
of transduction, we took advantage of the fact that both CARalA
and CARalB have an integrated Myc epitope, the levels of which
were comparable in both conditions (Fig. S3 A). Then, we
studied the effect of activated forms of both RalGTPases on SC
Figure 5. RalGTPases are dispensable for SC proliferation after peripheral nerve injury and in vitro. (A) Photomicrographs of longitudinal sciatic nerve
sections of ctrl and cRalA/B−/− 12 d after crush. (B) Percentage of nuclei positive for Ki67 of sciatic nerves 12 d after crush. (C) Scheme of the 4-OHT ad-
ministration on SCs for three consecutive days. SCs were left for 2 d with expansion medium. (D)Western blot to analyze the protein expression of RalGTPases
on SC cultures quantified in E and F. (G) Representative images of SC cultures fromWT and cRalA/B−/−mice. (H) Percentage of SCs positive for Ki67 in primary
culture experiments. Proliferating nuclei are labeled with Ki67 (red) and nuclei are labeled with DAPI (blue). **, P < 0.01, ***, P < 0.001, Student’s t test, n = 3 or
4. Data are presented as mean ± SEM. Scale bars, 50 µm.
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processes (Fig. S3). Overexpression of constitutive active RalA
(RalA72L) with CARalA lentivirus transduction and constitutive
active RalB (RalB32V; Lalli and Hall, 2005) with CARalB lenti-
virus transduction did not affect axial SC processes number and
length (Fig. S3, B–G). However, both activated GTPases increase
the radial lamellipodia number (Fig. S3 H). Interestingly, only
activated RalA was able to increase the radial prolongation
number (Fig. S3 I). None of the activated forms were able to
change the radial prolongation length (Fig. S3 J). To study which
Ral effectors are implicated in SC process formation, we chose
RalA mutant forms as activated RalA stimulated both radial
prolongations and lamellipodia formation. These constitutive
active RalAmutants have lost the ability to bind either the Exoc2
and Exoc8 subunits of the exocyst complex (RalA72LD49E;
Moskalenko et al., 2002; Lalli and Hall, 2005; herein called
CARalA-EC) or RalBP1 (RalA72LD49N; Lalli and Hall, 2005;
herein called CARalA-RBP1; Fig. 7). We confirmed that all these
lentiviral forms had the same efficiency of transduction in both
rat and mice SCs (Fig. S4). Interestingly, although the levels of
axial lamellipodia were not changed with CARalA, CARalA-RBP1
promoted the formation of axial lamellipodia (Fig. 7, A and B).
We did not observe any change in prolongation length follow-
ing transduction with any of the RalA mutants (Fig. 7, C and E).
For radial lamellipodia numbers, both CARalA-EC and CARalA-
RBP1 had comparable levels to the ones observed in GFP control
transduced SCs (Fig. 7, A and D). These results suggest that
both exocyst and RalBP1 are important for radial lamellipodia
formation.
Overall, the results obtained with the Ral mutants suggest
that activated forms of Ral are able to modify the SC processes,
and the ability of RalGTPases to interact with exocysts is an
important event for the formation of SC radial processes induced
by RalGTPases.
RalA enhances SC migration and axon myelination in an
exocyst-dependent manner
The directed migration and elongation in cells depend on the
ability to produce lamellipodia (Pankov et al., 2005). To study
the effect of RalGTPases on SC migration, we performed the
wound healing assay on WT rat SCs transduced with the con-
stitutive active forms of RalGTPases (Fig. 7, F and G; and Fig. S5
A). We observed that SCs transduced with CARalA had an in-
crease in the migration rate compared with control SCs (trans-
duced with GFP virus) 1 d after the wound injury in the culture
(Fig. 7, F and G). Interestingly, the constitutive active form of
RalB (CARalB) did not alter cell migration (Fig. S5 A). We ex-
amined which RalA effectors are important for the migration. In
SCs transduced with CARalA-EC, the SC migration levels were
significantly lower than the constitutive active form of RalA, and
migration was equal to that observed on control SCs, demon-
strating that interaction with the exocyst is essential for Ral-
dependent induction of SC migration in vitro. However, in SCs
transduced with CARalA-RBP1, we observed an increase in the
migration ratio similar to the one observed in CARalA-
transduced SCs (Fig. 7, F and G).
We previously described that myelinating co-cultures of rat
SC and human induced pluripotent stem cell (iPSC)–derived
Figure 6. Loss of RalGTPases results in disturbed SC prolongation and
lamellipodia formation. (A) Schematic representation of a SC showing axial
(AP) and radial (RP) prolongations and axial (AL) and radial (RL) lamellipodia.
(B) Scheme of the 4-OHT administration on SCs. (C) Images of SC cultures
from RalB−/− (control) and cRalA/B−/− mice to study the formation of axial
(white asterisks) and radial (yellow asterisks) SC lamellipodia and axial and
radial SC prolongations in vitro. Axial (D) and radial (E) lamellipodia number
per cell. (F) Representative images of three isolated SCs from RalB−/− and
cRalA/B−/− mice to study the prolongation length. (G and H) Axial (G) and
radial (H) prolongation average length. SC processes are stained with Talin
(green) and nuclei with DAPI. Data are presented as mean ± SEM (*, P < 0.05,
**, P < 0.01, Student’s t test, n = 3 for each genotype). Scale bars, 50 µm.
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Figure 7. RalGTPases enhance SC radial processes number, SC migration, and axon myelination in an exocyst-dependent manner. (A) Images of WT
rat SC cultures transduced with lentivirus containing GFP as a control; CARalA, a constitutive active form of RalA; CARalA-EC, an active constitutive form of
RalA unable to bind to exocyst; and CARalA-RBP1, a constitutive active form of RalA unable to bind to RalBP1. (B–E) Average of the number of axial (B) and
radial (D) lamellipodia per cell; axial (C) and radial (E) prolongation length quantification. GFP is labeled in green, the SCmarker S100 in red, and RalA and nuclei
(with DAPI) in blue. SC processes number and length are quantified in S100 channel for all S100-positive cells. (F and G) The wound healing assay revealed
differences in migration rate of SCs transduced with lentivirus containing the activated forms of RalGTPases. (F) Images of WT rat SC cultures for the wound
healing assay. (G)Quantification of the average number of cells invading the wound area. Transduced cells are GFP+ (green). (H) Images of human iPSC-derived
sensory neurons co-cultured with SCs transduced with lentivirus containing activated forms of RalA. (I) Viral transduction had no effect on axonal outgrowth.
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sensory neurons are a good model to study the axon–SC rela-
tionship in order to initiate alignment, basal lamina formation,
and myelination (Clark et al., 2017). To investigate the role of
RalGTPases inmyelination in this co-culture system, rat-derived
SCs were transduced with activated forms of RalGTPases before
the co-culture was performed. Viral SC transduction was well
tolerated by iPSC-derived sensory neurons with no visible signs
of cellular stress across different conditions (Fig. 7 H). Co-
cultures performed with SCs transduced with CARalA had a
significant increase in myelination compared with GFP-
transduced SCs (Fig. 7, H and J). CARalB, however, did not en-
hance the myelination of iPSC-derived sensory neurons (Fig. S5,
B and D). Interestingly, in co-cultures where SCs were trans-
duced with CARalA-EC, the degree of myelination was not en-
hanced and was similar to that observed in control GFP
virus–transduced SCs (Fig. 7, H and J). However, CARalA-
RBP1–transduced SCs were able to increase myelination versus
control similarly to CARalA transduced SCs (Fig. 7, H and J). We
did not observe any significant difference in axon area with any
of the activated forms of RalGTPases (Fig. 7, H and I). In sum-
mary, these results suggest that activation of exocysts by RalA is
important for SC migration and myelination, and gain of func-
tion of RalB does not enhance these SC functions.
RaGTPase is required for radial lamellipodia formation in an
exocyst-dependent manner
To demonstrate that SC process formation and extension are
dependent of RalGTPases, we transduced SCs derived from
cRalA/B−/− mice with lentivirus containing activated forms of
RalGTPases (Fig. 8). As expected, SCs derived from cRalA/B−/−
mice transduced with CARalA or CARalB mutants recovered SC
process formation and extension observed in control SCs
transduced with Lv-GFP (Fig. 8). CARalA-EC did not, however,
rescue the radial lamellipodia number per cell to the levels ob-
served in control SCs (Fig. 8 D) but rescued axial lamellipodia
(Fig. 8 B) and prolongation lengths (Fig. 8, C and E). These re-
sults demonstrate that SC processes are regulated by RalGTPases
and that exocyst activationmediated by RalGTPases is important
for radial lamellipodia formation in SCs.
Discussion
In this study, we have shown that RalGTPase signaling within
SCs contributes to optimal nerve repair. RalGTPases were re-
quired for the formation and extension of both axial and radial
processes of SCs. Enhanced RalGTPase signaling could enhance
both SC migration and myelination. These effects were depen-
dent on interaction with the exocyst complex.
Ral GTPase signaling contributes to effective nerve repair
Our data in transgenic animals lacking both GTPases demon-
strated that RalGTPases were dispensable for themaintenance of
axon integrity and the myelin sheath in the naive state in
adulthood. However, the absence of RalGTPase signaling in SCs
seriously impaired the regenerative process following nerve
injury: we found that RalGTPases played an important role in
axon remyelination, the reinnervation of distal organs, and
restoration of motor function after injury. There was significant
redundancy in that ablation of RalA or RalB individually had no
impact on nerve repair. Such redundancy has previously been
observed in studies of the role of RalA and B in development and
tumorigenesis (Peschard et al., 2012). Interestingly, when we
examined the expression of RalGTPases in the distal nerve
stump of WT mice following injury, we observed a complex
pattern with decreased expression of RalA and increased ex-
pression of RalB.When assessing the activated forms of RalA and
B, however, there was a trend for enhanced activation of RalA
and significantly reduced activation of RalB following nerve
injury. It has been previously noted that changes in the ex-
pression are not necessarily correlated with activation status of
RalGTPases (Peschard et al., 2012). Despite the differential ex-
pression between RalA and B, there was clear redundancy at a
functional level when individually ablated.
The regeneration process following nerve injury includes
dedifferentiation of SCs to a regenerative state followed by re-
differentiation, association with regrowing axons, and forma-
tion of a myelin sheath (Chen et al., 2007; Arthur-Farraj et al.,
2012). There were morphological differences in the outcome of
nerve repair following sciatic nerve crush in cRalA/B−/− mice
versus ctrl, and in particular RalGTPases were required for axon
remyelination. In cRalA/B−/− mice, we observed that (1) the
density of axons of >1 µm that were unmyelinated was increased
and (2) those axons that were myelinated had a thinner myelin
compared with ctrl mice. These features were observed at 12 d
and 1 mo after injury. In addition to this deficit in radial mye-
lination, we found that in the absence of RalGTPases signaling
internodal length was shorter. In contrast, we did not observe
any changes in nonmyelinating SCs and their associated C-
fibers: the number of C-fibers per Remak bundle and the
number of Remak bundles in the injured nerve did not change
after RalGTPases ablation.
We also observed a decrease in reinnervation of the neuro-
muscular junction of the gastrocnemiusmuscle 1 mo after injury
in cRalA/B−/−. In these animals, RalB is absent in regenerating
axons as well as SCs. However, the fact that we did not observe
any difference in neuromuscular junction reinnervation after
injury in RalB−/− mice suggests that the likely explanation for
this phenomenon is impaired RalGTPase signaling in SCs. One of
the steps of SC repair response to injury is the formation of
regeneration tracks (Chen et al., 2007). After injury, SCs change
to a more bipolar morphology, they elongate and align to form
a SC column named a band of Bungner, and SCs also form
“bridges” at points where there is a loss of nerve integrity
(particularly relevant to axotomy; Parrinello et al., 2010). These
(J) CARalA- and CARalA-RBP1–transduced SCs significantly promote myelination of human iPSC-derived sensory neurons. In contrast, CARalA-EC–transduced
SCs had no effect on the myelination compared with GFP-transduced SCs. n = 3 for each virus condition and experiment. Data are presented as mean ± SEM (*,
P < 0.05, ***, P < 0.001, one-way ANOVA, post hoc Tukey’s test used to compare with GFP-transduced rat SCs). Scale bars, 50 µm.
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columns form tracks along the distal regenerating nerve and
provide guidance to axons to achieve their distal organs. We
have observed a trend in the reduction of SC axial prolongations
and a decrease in their elongation in vitro in SCs from cRalA/B−/−
(discussed below), which could impede these close SC–axon
interactions. Terminal SCs within the muscle have also been
shown to be critical in synaptic reinnervation by motor axons
(Balice-Gordon, 1996; Kang et al., 2014). As well as physical in-
teractions, it is also possible that RalGTPase-deficient SCs pro-
duce fewer growth factors for axons (Jessen and Mirsky, 2016).
The functional recovery from nerve injury was impaired in
cRalA/B−/− mice. The SFI is a measure of motor functional
recovery: we noted significant delay in the recovery of SFI fol-
lowing nerve crush in the absence of both RalGTPases. Inter-
estingly, the recovery was delayed rather than prevented, and
by 28 d after injury, there was no longer a significant difference.
Although remyelination and target reinnervation had not com-
pletely normalized at this stage, they were clearly sufficient for
reasonable performance in this assay. We also tested sensory
function by using the pin prick test to determine cutaneous
reinnervation of the hindpaw. This was not significantly dif-
ferent in cRalA/B−/− mice, consistent with the fact that we did
not observe any morphological alterations in Remak bundle
structure in these mice.
Figure 8. Activated RalGTPases rescue SC process formation on cRalA/B−/−-derived SCs. (A) Images of SC cultures fromWT rat transduced with GFP as a
control (Ctrl GFP) and from cRalA/B−/− mice transduced with lentivirus containing GFP as a control; CARalA, a constitutive active form of RalA; CARalA-EC, a
constitutive active form of RalA unable to bind to exocyst, and CARalA-RBP1, a constitutive active form of RalA unable to bind to RalBP1. (B–E) Average of the
number of axial (white asterisks; B) and radial (yellow asterisks; D) lamellipodia per cell; and axial (C) and radial (E) prolongation length quantification. SC
processes number and length are quantified in S100 channel for all S100-positive cells. GFP, green; S100, red; DAPI, blue. n = 3 for each virus condition and
experiment. Data are presented as mean ± SEM (*, P < 0.05, one-way ANOVA, post hoc Tukey’s test used to compare with GFP-transduced control SCs). Scale
bar, 50 µm.
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We examined the proliferation of SCs as well as myelin
clearance in case these could provide insight into defective nerve
repair in cRalA/B−/− mice. Nerve injury and repair is associated
with two phases of SC proliferation: the first is due to loss of
axonal contact and peaks around 3 d after injury (Carroll et al.,
1997; Bradley et al., 1998; Stoll and Müller, 1999; Griffin and
Thompson, 2008); the second occurs as axons enter the dener-
vated nerve stump (Pellegrino and Spencer, 1985). RalGTPases
promote cell proliferation in some models of cancer (Gentry
et al., 2014) and, of particular relevance, in some lines of ma-
lignant peripheral nerve sheath tumors (Bodempudi et al.,
2009). Ral GTPases have also been shown to interact with the
small GTPase cdc42, which activates SC proliferation during
development (Benninger et al., 2007). Active (GTP-ligated) Ral
associates with RalBP1. RalBP1 is a GTPase-activating protein for
Cdc42, which it deactivates (Matsubara et al., 1997). We there-
fore investigated the role of RalGTPases in the proliferation of
SCs following nerve injury. Cellular proliferation within the
distal nerve stump at 12 d after injury was not altered in the
absence of both RalGTPases. Furthermore, the proliferation of
SCs in vitro did not change in the absence of RalGTPase.
A further early event in peripheral nerve repair is the
clearance of myelin debris (Chen et al., 2007). Both phagocytosis
of myelin by macrophages as well as phagocytosis and autoph-
agy of myelin by SCs contribute to myelin clearance (Gomez-
Sanchez et al., 2015; Velasquez et al., 2018). We did not find any
change in myelin clearance during the regeneration process
in vivo in cRalA/B−/− mice.
RalGTPases are required for the SC processes formation and
extension, SC migration, and axon myelination
The dynamic interactions between SCs and axons in the distal
nerve stump are critical for successful nerve repair (Arthur-
Farraj et al., 2012). This requires significant morphological
changes in SCs; for instance, repair SCs are reportedly two- to
threefold longer than quiescent myelin and Remak SCs (Gomez-
Sanchez et al., 2017). Other small GTPases, particularly of the
Rho family, such as Rac1 and cdc42, have been shown to be
critical for SC process formation and myelination during de-
velopment and after repair (Nodari et al., 2007; Stendel et al.,
2007; Park and Feltri, 2011; Guo et al., 2012, 2013). We therefore
investigated the role of RalGTPases on SC process formation.
Our in vitro assays demonstrated that the ablation of RalA and
RalB GTPase in SCs reduced their ability to form normal axial
and radial lamellae. As well as studying loss of function, we
interrogated the effect of enhancing the activity of individual
RalGTPase on the SC processes formation, migration, and mye-
lination. The active forms of RalA and B enhanced radial la-
mellipodia formation. The cellular phenotype of SCs transduced
with active forms of RalGTPases was not, however, the exact
opposite of RalGTPases—null cells in that axial lamellipodia
number and axial prolongation length were not enhanced. This
difference may reflect the “set point” of GTPase signaling within
the cell, and the stimulus-response function may differ between
axial and radial processes (Pankov et al., 2005; Nodari et al.,
2007); there may also be differences in the role of RalGTPases
for maintenance of SC processes versus increasing the length or
enhancing formation of new processes. There were some dif-
ferences in comparing the effects of active RalA versus RalB:
both GTPases increased radial lamellae; however, only RalA in-
creased radial prolongation numbers. The directed migration
and elongation of cells depend on their ability to produce la-
mellipodia (Pankov et al., 2005). Furthermore, radial lamelli-
podia formation by SCs is required for initial axon ensheathment
and then wrapping during the process of myelination (Bunge
et al., 1989; Nodari et al., 2007; Montani et al., 2014). Consis-
tent with the effect of RalA on SC process formation, we ob-
served an increase in SCmigration by the activated form of RalA.
We also found that the activated form of RalA enhanced myeli-
nation in an in vitro co-culture assay. In contrast to RalA, the
active form of RalB did not enhance SCmigration or myelination
in vitro, consistent with the fact that RalB was less effective at
promoting process formation.
An important effector of RalGTPases is interaction with and
activation of the exocyst complex. We therefore studied a
RalGTPase mutant that is unable to attach and activate exocysts.
This failed to increase (1) migration rate, (2) axon myelination,
and (3) rescue of the SC morphology observed in SCs derived
from cRalA/B−/− mice, suggesting a specific role for the exocyst
complex in mediating the effects of Ral on SC morphology and
function. This Ral-exocyst signaling may regulate process for-
mation and ultimately migration and myelination via a number
of mechanisms, including (1) the targeted delivery proteins such
as P0, myelin-associated glycoprotein, or laminin by exocytosis
(Chen et al., 2012); (2) addition of membrane to plasma mem-
brane (Trapp et al., 1995); or (3) the polarization of SCs, which is
known to be a critical for myelination (Lewallen et al., 2011;
Shen et al., 2014). RalGTPases also interact with RalBP1; how-
ever, our in vitro experiments using forms of RalGTPases, which
are unable to activate RalBP1, demonstrated that this does not
appear to be an effector by which RalGTPase enhances process
outgrowth, SC migration, and myelination.
In conclusion, we have identified that RalGTPase activity in
SCs contributes to effective nerve repair and specifically for the
axial and radial elaboration of myelin by SCs as they interact
with regenerating axons. We found that RalGTPases are re-
quired for the formation of SC processes through their interac-
tion with the exocyst complex. This provides a further example
of the critical role of SCs in coordinating effective nerve repair,
and such signaling could potentially be targeted therapeutically.
Materials and methods
Transgenic mice
All procedures were performed in accordance with UK Home
Office regulations (Mice Scientific Procedures Act, 1986). RalAfl/fl
and RalB−/− mice were provided by C. Marshall (Institute of
Cancer Research, London, UK) and the generation and geno-
typing of these mice has previously been described (Peschard
et al., 2012). cRalA and cRalA/B−/− were bred by crossing
PLPCreERT2 (Doerflinger et al., 2003) and JAX-005975 (http://
jaxmice.jax.org/strain/005975.html) with RalAfl/fl and RalAfl/fl;
RalB−/−, respectively. Conditional ablation of RalA in SCs (here
called cRalA) and conditional ablation of RalA in SCs of RalB KO
Galino et al. Journal of Cell Biology 2381
Ral contributes to SC processes and repair https://doi.org/10.1083/jcb.201811002
D
ow
nloaded from
 https://rupress.org/jcb/article-pdf/218/7/2370/868687/jcb_201811002.pdf by guest on 22 April 2020
mice (here called cRalA/B−/−) were generated by administering
tamoxifen (0.25 mg/g body weight in corn oil; T5648; Sigma-
Aldrich) by oral gavage for five consecutive days to 8-wk-old
PLPCreERT2:RalAfl/fl (cRalA) mice or PLPCreERT2:RalAfl/fl:RalB−/−
(cRalA/B−/−) mice, respectively. Tamoxifen was administered 4
wk before surgery. For both experiments, one type of con-
trol mice was used for comparison: tamoxifen control mice
(ctrl), which are tamoxifen-treated Cre-negative littermates
(i.e., Ralfl/fl or RalAfl/fl:RalB−/−, respectively). To detect the
PLPCreERT2 construct, PCR of genomic DNA using the
following primers was performed: 59-AGGTGGACCTGATCA
TGGAG-39 and 59-ATACCGGAGATCATGCAAGC-39 (performed
as follows: heating at 94°C for 3 min, 40 cycles of 94°C for 30
s, 52°C for 30 s, and 72°C for 30 s, followed by a final extension at
72°C for 8 min). In PLPCreERT2mice, a tamoxifen-inducible form
of Cre recombinase is expressed in SCs by the PLP promoter
(Doerflinger et al., 2003). For experiments comparing WT and
RalB−/− mice, heterozygous mice for RalB mutant allele (RalB+/−)
were bred together, and WT and RalB−/− littermates were
used for experimental procedures. Wherever possible, an equal
number of mice of each gender in each experimental groupwere
included. This study conforms to the Animal Research: Report-
ing of In Vivo Experiments guidelines. Each scientific question
in which statistical analysis was performed was addressed with
a sample size chosen based on a power calculation using his-
torical data relating to SFI responses (α error of 0.05 and a
power of 80%). This calculation was suggesting a minimal co-
hort size of 3–6 for anatomical and 8–12 for behavioral studies.
The sample size for each experiment is indicated in the corre-
sponding figure legend. Samples were allocated into experi-
mental groups based on their genotype. The experimenter was
blinded to the group allocation during the experiment and/or
when assessing the outcome.
Surgery
Surgery was performed in 13-wk-old mice (in those mice that
had been treated with tamoxifen, this was 4 wk after treatment).
Under sterile conditions and inhalational anesthesia, the left
sciatic nerve was exposed and crushed twice, in two different
directions for 30 s each time, with fine forceps. In all cases, the
lesion site was kept constant, and the wound was closed with
6–0 sutures and disinfected. Post-surgery analgesia drugs were
given to the mice, and autotomy and weight loss weremonitored
daily for the first week after surgery and three times per week
later on.
Lentivirus production
All Ral mutant constructs were a gift from G. Lalli, Kings College
London, London, UK (Lalli and Hall, 2005). The subcloning of
Ral constructs to viral vectors, viral packaging, CsCl purification,
and viral genome titration were performed by Creative-Biogene.
All lentivirus was made with a ZsGreen1 protein linked to the
specific RalGTPase construct RalA72L (CARalA), CARalA-EC,
CARalA-RBP1, and RalB23V (CARalB) with an IRES sequence as a
linker. Primary rat and mice SCs were transduced 1 wk after the
culture was established onto coverslips. For all cell trans-
ductions, the stock virus was diluted in DMEM to obtain the
correct multiplicity of infection of 5–10 based on the number of
cells per coverslip.
Mouse and rat SC purification
For mice SC purification, sciatic nerves from pups on postanal
day 8–10 were dissected and placed in HBSS on ice. The epi-
neurium and superfluous connective tissue were removed using
forceps. Desheathed nerves were then cut into 5-mm segments
and were enzymatically digested with a collagenase (3 mg/ml;
Sigma-Aldrich) and dispase II protease (2.5 mg/ml; Sigma-
Aldrich) incubation for 1 h at 37°C. Nerves were gently triturated
using a P1000 and then a P200 pipette tip and plated onto poly-
D-lysine (Sigma-Aldrich)/laminin (R&D Systems)–coated cov-
erslips in SC expansion medium (DMEM without L-glutamine
and with D-valine to avoid fibroblast contamination; custom-
made by Cell Culture Technologies), 10% horse serum (Thermo
Fisher Scientific), 200 ng/ml NRG1-β1 EGF domain (R&D Sys-
tems), 10 ng/ml NGF (recombinant-murine; Peprotech), 4 µg/ml
forskolin (Sigma-Aldrich), and GlutaMAX (Invitrogen) for 1 wk
until the myelin and other cell debris were completely removed,
changing medium three times that week. Mouse SC cultures
were then treated with 2 µM 4-OHT for 1 d and the day after
with 1 µM for two consecutive days. SCs were either left for 2 d
with expansion medium or replated and left in serum-free
medium for 1 d followed by 4 h of expansion medium. In ex-
periments that needed the lentivirus transduction in mice SCs,
this was performed on the second day of 4-OHT treatment
(Fig. 8 A). For serum-free conditions, SCs were cultured in de-
fined media (DMEM/F12 media supplemented with 10 mg/liter
forskolin, 10 µM putrescine, 20 nMprogesterone, 30 nM sodium
selenite, and GlutaMAX).
Rat SCs were purified as described by Clark et al. (2017). SCs
were harvested from the sciatic nerve and brachial plexus of
postnatal day 3 or 4 rats. Nerves were enzymatically digested
with a collagenase (3 mg/ml; Sigma-Aldrich) and dispase II
protease (2.5 mg/ml; Sigma-Aldrich) incubation for 1 h at 37°C.
Nerves were gently triturated using a glass-blown pipette and
plated onto poly-D-lysine/laminin-coated plastic in DMEM/F12
(Thermo Fisher Scientific) and 10% FBS (Thermo Fisher Scien-
tific). From the day after, SCs were kept in expansion medium
(DMEM/F12, 10% FBS, 10 mM NRG1-β1 EGF domain [R&D Sys-
tems], 10 ng/ml NGF [recombinant-murine; Peprotech], and
4 µM forskolin [Sigma-Aldrich]). Cells were serially treated with
5–10 µM araC to eliminate fibroblasts. After approximately four
passages, each time doubling the growing area, cells were frozen
in a Mr. Frosty freezing container (Thermo Fisher Scientific)
and stored in liquid nitrogen. The cells were transduced with
lentivirus at multiplicity of infection 5–10 and fixed 3–4 d after
transduction.
SC migration
Rat SCs were transduced with lentivirus at multiplicity of in-
fection 10 and plated in 4-well plates at a concentration of 5 × 104
cell/well, in triplicate for each condition. After reaching the
confluence, a gentle scratch in the well was done with a P200 tip
without touching the poly-D-lysine/laminin coating, and marks
were done on the plate in order to easily identify the area.
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Establishing the myelinating co-cultures
iPSC generation, maintenance, and differentiation to neuronal
culture was performed as described by Clark et al. (2017). To
establish the co-cultures, the medium on the neuronal cultures
was changed from N2 to SC basal medium (DMEM/F12 [Thermo
Fisher Scientific], 5 mg/ml insulin [Sigma-Aldrich], 100 mg/ml
transferrin [Millipore], 25 ng/ml NGF [recombinant-human;
Peprotech], 25 ng/ml selenium [Sigma-Aldrich], 25 ng/ml
thyroxine [Sigma-Aldrich], 30 ng/ml progesterone [Sigma-
Aldrich], 25 ng/ml triiodothyronine[Sigma-Aldrich], and 8 mg/
ml putrescine [Sigma-Aldrich]). Transduced SCs (25,000) in a
25-µl droplet were slowly pipetted onto a single coverslips
containing the iPSC-derived sensory neurons, with care taken
not to touch the coverslips with the pipette tip. The SC droplet
was evenly distributed over the coverslip. Cultures were care-
fully put back into the incubator to allow SC adherence. The
culture medium was changed 2 d later. At this stage, abundant
SCs could be observed adhered to the coverslip. An additional SC
basal medium change was performed 4 d after adding the SCs.
Myelination was induced 1 wk after SC addition by exposing the
cells to myelination medium (N2 medium, 1:300 phenol-free
Matrigel [Scientific Laboratory Supplies], 5% charcoal-stripped
FBS [Thermo Fisher Scientific], 25 ng/ml NGF [recombinant-
human; Peprotech], and 50 mg/ml ascorbic acid [Sigma-
Aldrich]). Medium changes were performed twice weekly from
then on. The myelin quantification by immunocytochemistry
was performed 4 wk after transduced SC addition as reported by
Clark et al. (2017).
Western blotting
Tissues and primary SC cultures were homogenized in NP-40
lysis buffer (20 mM Tris, pH 8, 137 mM sodium chloride, 10%
glycerol, 1% NP-40, 2 mM EDTA, 20 µM leupeptin, 1 mM PMSF,
1 mM sodium orthovanadate [all from Sigma-Aldrich], 5 mM
sodium fluoride [BDH], and protease inhibitor cocktail [Roche])
with a Dounce (Sigma-Aldrich) and a syringe, respectively. The
lysates were kept rotating at 4°C for 90 min, then spun at
13,000 rpm at 4°C for 15 min, and the protein concentration of
supernatant was determined using a BCA Protein Assay kit
(23227; Thermo Fisher Scientific). 10–30 µg of protein was
mixed with SDS gel sample buffer, electrophoresed on 8–14%
Mini-PROTEAN TGX Precast Protein Gels (Bio-Rad), and trans-
ferred to Immobilon-P Membrane, polyvinylidene fluoride,
0.45-µm membranes (Millipore). Blocking was done in 3% BSA
(Europa Bioproducts) and PBS. Primary antibodies used were
αms RalA (BD Transduction Laboratories) at a dilution of 1 to
1,000, αrt RalB (R&D Systems) at a dilution of 1 to 500, αmsMyc
(Cell Signaling) at a dilution of 1 to 500, αrb calnexin (Enzo Life
Science) at a dilution of 1 to 1,000, and αms GAPDH (ab8245;
Abcam) at a dilution of 1 to 1,000. Secondary antibodies used
were anti-rabbit IgG HRP linked (NA9340V; GE Healthcare) and
anti-mouse IgG HRP linked (NA931V; GE Healthcare) at 1 to
20,000, and anti-rat (DAKO) at 1 to 5,000. The ECL prime
Western blotting detection system (GE Healthcare) was used to
visualize the immunoreactive band on chemiluminescence film
(GE Healthcare). For quantification and analysis, the intensity of
specific bands was quantified using ImageJ. Each band detected
by RalA and RalB was normalized against loading control cal-
nexin or GAPDH correspondingly for analysis.
Immunoprecipitation and RalGTPase activity
RalGTPase activity in vivo was assessed using the Ral activation
assay (New East Bioscience) following product guidance with
some modifications. Homogenates of a pool of two sciatic nerves
from two different animals, to generate each data point, with
immunoprecipitation Lysis Buffer (50 mM Tris-HCl, 125 mM
NaCl, 1% NP-40, 0.1% SDS, and anti-proteases), were incubated
for 1 h at RTwithmagnetic beads (Bio-Rad) previously incubated
with 1 µg of anti-active Ral antibody (New East Bioscience) for
10 min. To elute the antigen from the bead-antibody complex,
the beads were incubated 10minwith 40 µl of 1× Laemmli buffer
at 70°C. Immunoprecipitation products were then loaded into
12% Mini-PROTEAN TGX Precast Protein Gels (Bio-Rad) and
transferred to an Immobilon-P Membrane, polyvinylidene flu-
oride, 0.45-µm membranes (Millipore). Finally, membranes
were incubated with antibodies against anti-RalA or -RalB, as
described in the Western blotting section, to detect activated
forms of RalA and RalB, respectively.
Immunohistochemistry
Mice were deeply anaesthetized with pentobarbitone and
transcardially perfused with either 5 ml saline or 5 ml saline
followed by 25 ml paraformaldehyde (4% in 0.1 M phosphate
buffer [PB]). Gastrocnemius muscle and sciatic nerves were
post-fixed in paraformaldehyde (4% in 0.1 M PB) for 30 min
(muscle) and 1 h (sciatic nerve) and then transferred to 30%
sucrose for 3 d. Tissue was then mounted in optimal cutting
temperature embedding compound on dry ice and stored at
−80°C. Sciatic nerves for nerve teasing were post-fixed in par-
aformaldehyde (4% in 0.1 M PB) for 30 min and stored in PBS,
0.1% NaAz at 4°C.
For muscle staining, longitudinal sections of gastrocnemius
were cut on a cryostat in 100 µm sections and transferred into a
24-well plate and stored in PBS containing 0.1% NaAz followed
by incubation with antibodies against the presynaptic marker
αms SV2 (1 in 100; DSHB) and axon marker αms 2H3 (1 in 50;
DSHB) and tetramethyl-rhodamin–conjugated α-bungarotoxin
(1 in 1,000; Invitrogen) to stain the post-synaptic acetylcholine
receptors. Sections were washed three times with PBS, followed
by incubation in blocking solution (PBS, 5% normal donkey se-
rum, 1% BSA, 1% DMSO, 0.5% milk protein, 0.3% Triton X-100,
and 0.1% NaAz) for 30min at RT. Immunoreaction with primary
antibodies 2H3, SV2, and MBP was performed by incubation
overnight at RT in PBS and 0.2% Triton X-100. After washing in
PBS, corresponding secondary antibodies and α-bungarotoxin
were diluted in PBS and 0.2% Triton X-100 and incubated for
2.5 h at RT. Sections were washed, transferred to slides, and
mounted with Vectashield mounting medium for fluorescence
(VECTOR). The total number of neuromuscular junctions and
the number that were innervated by axons were counted using
ImageJ.
For Ki67 staining, longitudinal sections of sciatic nerve were
cut on a freezing microtome in 14 µm sections. Sections were
stained for the proliferation marker Ki67. Before Ki67 staining,
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nerves were incubated with an antigen retrieval buffer (10 mM
citrate buffer, pH 6.2) overnight at 60°C. After washing, the
sections were incubated with primary antibody αrb Ki67 (Ab-
cam) dilution 1 to 500 overnight at RT in PBS and 0.2% Triton X-
100. Slides were washed three times with PBS for 5 min each,
incubated in the corresponding secondary antibody containing
DAPI (1 to 50; Invitrogen), and diluted in antibody buffer for
2.5 h at RT. Slides were washed three times with PBS for 5 min
and mounted with Vectashield mounting medium for fluores-
cence (VECTOR) and examined with the confocal Zeiss LSM 700
laser scanning microscope.
For nerve teasing in order to measure internodal length,
sciatic nerves were incubated with 0.5% osmium tetroxide
(TAAB) for 2 h followed by three washes of 5 min each with 25%
EtOH, 50% EtOH, and 75% EtOH. Nerves were stored in 50%
glycerol and 50% of 70% EtOH and teased in glycerol. Sciatic
nerves were teased under a microscope. The perineurium was
removed from the fascicles using fine forceps and sharp nee-
dles. Nerve bundles were divided until single fibers could be
teased out. Slides were covered with vectashield mounting
medium for fluorescence (VECTOR) and analyzed at the con-
focal microscope.
For immunostaining of teased nerves, sciatic nerves were
fixed in 4% PFA for 30 min. After perineurium removal, the
sciatic nerve was teased as described above. Fibers were then
incubated with primary antibodies in blocking buffer (1% BSA in
PBS) overnight at 4°C. Incubationwith secondary antibodies was
done in blocking buffer for 1 h at RT. Primary antibodies used
were monoclonal αms RalA (610222BD), 1 to 50, and αrb S100
(Z0311; DAKO), 1 to 300.
Immunocytochemistry
Primary rat and mice SCs and human iPSC-derived sensory
neurons–SCs co-culture were fixed in 4% PFA for 10 min at RT.
Primary cells were then permeabilized with 0.2% Triton X-100
for 5 min at RT, whereas the co-cultures were permeabilized
with cold MeOH for 20 min on ice. Cells were incubated with
primary antibody in blocking buffer (1% BSA in PBS) overnight
at 4°C, followed by incubation with secondary antibodies in
blocking buffer for 2.5 h at RT. Primary antibodies used in im-
munocytochemistry were monoclonal αms RalA (610222; BD
Biosciences), 1 to 50; αrb S100 (Z0311; DAKO), 1 to 300; αrb Ki67
(ab16667; Abcam), 1 to 500; αck GFP (ab13970; Abcam), 1 to 200;
αgt Talin (sc-7534; Santa Cruz Biotechnology), 1 to 50; αms Myc
(2276s; Cell Signaling Technology), 1 to 500; αms neurofilament
heavy chain (ab7795; Abcam), 1 to 10,000; αrt MBP (ab7349;
Abcam), 1 to 400; and αrb S100 (GA504; DAKO), 1 to 300.
Image acquisition and analysis
Images were taken with the Axio Camera of the Zeiss Imager Z1
microscope and using Carl Zeiss ZEN SP1 black software.
Reinnervation of the gastrocnemius was quantified by taking
∼10 pictures of each animal muscle at 20× magnification with a
Z-stack through the entire thickness of themuscle section. Using
ImageJ software, the ratio of the total number of innervated
endplates and the total number of endplates was used for the
percentage of reinnervated endplates. The ratio of reinnervated
endplates that are myelinated and the total number of re-
innervated endplates was used for the percentage of myelinated
endplates.
In vivo cell proliferation was quantified using ImageJ in ap-
proximately five pictures at 20× magnification with a Z-stack of
each nerve in which all Ki67 positive nuclei were counted and
normalized by the total number of nuclei (750 per animal), in-
dicating the percentage of proliferating cells.
In vitro SC proliferation was quantified in approximately five
random tile scan pictures of each culture (300 cells per culture)
using ImageJ.
For internodal distance, 70–100 lengths per animal were
measured using the ImageJ ROI Manager software.
For the study of the SC processes extension and formation,
primary rat and mice SC cultures were used. The number and
length of all radial and axial prolongations (all major cyto-
plasmic process extensions of the cell) and the number of radial
and axial lamellipodia (thin cytoplasmic sheets extended at the
edge of an axial prolongation or in radial plane of the SCs) were
analyzed. SC processes at the two extremities of the main cell
axis were considered axial prolongation/lamellipodia, and the
ones opposite to the main cell axis were considered radial
prolongation/lamellipodia (for more clarification, follow the
scheme in Fig. 5 A). For each independent mouse/rat-derived
SC primary culture, three coverslips were plated and analyzed.
30–40 SCs were randomly chosen per coverslip to count pro-
longations and lamellipodia per cell and measure the length of
the prolongations.
For the quantification of transduction efficiency, primary
mouse and rat SCs were used. The percentage of S100/GFP-
positive cells was calculated analyzing four images for each
condition. Images were taken at 10× magnification for mouse
SCs and 20× magnification for rat SCs. The intensity of GFP
fluorescence in single cells was calculated analyzing 50 cells
for each condition. Intensity was measured using the ImageJ
software in pictures taken with exactly the same setting
conditions.
For the quantification of the migration area, representative
pictures were taken immediately after the scratch and 24 h later
with the fluorescence microscope. Taking advantage of the
ZsGreen1 protein linked to each RalGTPase construct, migrating
SCs were quantified using the ImageJ software, and each count
was normalized for the area of the scratch in square millimeters.
For the quantification of myelination in co-cultures, Zen
Black Software (Zeiss) was used to create a digital diamond
shape of 13 points (2-mm horizontal/vertical distance between
each point) that was centered on each coverslip. A tile scan (each
1,792 × 1,792 µm in size, using a 20× objective) was taken at each
point, resulting in 13 nonoverlapping images that equally sam-
pled all quadrants of the coverslip (31.4% of the total area). Im-
ages were processed and analyzed using ImageJ software
(version 1.48J). A condition-blinded investigator then created
binary images for each channel (MBP and NF200 [eurofilament
heavy chain]) by adjusting the threshold to acquire the maxi-
mum signal-to-noise ratio, and area measurements for each
channel were recorded. The proportion of axonal area covered
by myelin was then calculated as reported in Clark et al. (2017).
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Electron microscopy
Sciatic nerves were dissected, and a section 2–3 mm distal to the
crush site on the injured side and an equivalent level on the
uninjured side were processed for EM. Sciatic nerves were post-
fixed with 4% PFA and 3% glutaraldehyde in 0.1 M PB and
processed as previously described (Fricker et al., 2009). Nerves
were osmicated with 1.5% osmium/0.2 M PB for 90 min, dehy-
drated, and embedded in epoxy resin (TAAB). Ultrathin sections
(90 nm) were cut using a Diatome diamond knife on the Leica
UC7 ultramicrotome and mounted onto 100 mesh Cu grids
coated with formvar. Sections were post-stained for 5 min with
lead citrate. Pictures were taken with a FEI Tecnai T12 trans-
mission electron microscope at the Dunn School Bioimaging
facility (University of Oxford). For analysis, photographs
of randomly chosen entire grid squares were taken, the area of
which totaled at least 20% of the total area of the cross section of
the sciatic nerve. Macrophages were identified as cells con-
taining foamy lipid bodies, and myelin ovoids as individual
swirls of unraveling myelin. The numbers of macrophages,
myelin ovoids, and myelinated and unmyelinated axons were
counted from these montages of grid squares and normalized to
square millimeters. Analysis was done using ImageJ Software.
To calculate g-ratios, 10–20 electron micrographs were ran-
domly picked using randomly generated numbers. All myeli-
nated axons within each picture were measured to calculate the
g-ratio, and all unmyelinated axons in each picture were mea-
sured for axon diameter using AxioVision LE Rel. 4.2 software.
The examiner was blind to genotype.
Behavioral analysis
The same designated room was used for all behavioral studies,
and testing was performed at a consistent time of day.Micewere
acclimatized to the testing equipment, and baseline values were
obtained. All behavior studies were performed with the exper-
imenter blind to treatment group or genotype. Baseline values
were performed in order to determine that behavioral outcomes
at baseline were within the normal range and no mice required
exclusion from the behavioral analysis on this basis.
For SFI, mice were trained to run along a wooden 1-m-long
catwalk into a dark box at the far end. The catwalk was covered
with a piece of paper with the same dimensions, and the hind
paws of the mice were inked with stamp ink. Mice ran along the
catwalk, leaving their paw prints on the paper. The paper strips
were left to dry, and measurements were manually taken. Paw
prints used for measuring were chosen based on clarity and
consistency and a succession of three or four prints at a point at
which the mouse was walking at a moderate pace. Both unin-
jured and injured paw prints were measured. Measurements
were as follows: toe spread, the distance between the first and
fifth toes; intermediate toe spread, the distance between the
second and fourth toes; and print length, the distance between
the end of the third toe and the bottom of the hind pad. These
measurements were used to calculate the SFI (Bain et al., 1989;
Monte-Raso et al., 2008).
For the pin prick test, the skin of the foot was pinched by an
insect pin (Austerliz) in the pads and toes in the lateral and
medial parst. Sciatic nerve innervation of the skin in the lateral
part (innervated by sural and tibial nerve) was measured as a
reinnervation of the skin after sciatic nerve injury. Each pad or
digit pinched was scored 0 for nonreflex withdrawal response of
the paw, 1 for mild reflex withdrawal response, and 2 for good
reflex withdrawal response.
Statistics
All statistical analysis has been performed using GraphPad
Prism 6 software. Data were reported as mean ± SEM, and the
number of replicates was indicated in each figure legend. The
level of significance was set at P < 0.05. The two-tailed unpaired
Student’s t test was used to analyze differences between two
groups. One-way ANOVA followed by the Tukey post hoc test
was used for the analysis of more than two groups. To assess
statistical differences in behavior experiments with multiple
time points, repeated measures two-way ANOVA was per-
formed with Sidak’s multiple comparison tests. Distribution
plots have been performed with Excel software, and the
Kolmogorov-Smirnov test in SPSS has been used for statistical
analysis of the distributions. Statistical analysis for each panel is
specified in the figure legend. For parametric tests, data distri-
bution was assumed to be normal, but this was not formally
tested. The experimenters were blind to group/treatment dur-
ing data acquisition and analysis before unblinding for statistical
analysis.
Online supplemental material
Fig. S1 shows the phenotypic outcome of injured RalB−/− mice.
Fig. S2 shows the phenotypic outcome of injured cRalAmice. Fig.
S3 shows differences in comparing the effects of active RalA
versus RalB on SC process formation. Fig. S4 shows transduction
efficiency of the lentivirus. Fig. S5 shows the effect of active RalB
on SC migration and axon myelination.
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